Relmada Therapeutics
RLMD
RLMD
134 hedge funds and large institutions have $954M invested in Relmada Therapeutics in 2022 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 46 increasing their positions, 33 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% more funds holding
Funds holding: 113 → 134 (+21)
3.48% more ownership
Funds ownership: 82.3% → 85.77% (+3.5%)
41% less call options, than puts
Call options by funds: $117M | Put options by funds: $198M
Holders
134
Holding in Top 10
7
Calls
$117M
Puts
$198M
Top Buyers
| 1 | +$83.7M | |
| 2 | +$15.5M | |
| 3 | +$9.01M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$6.48M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$5.57M |
Top Sellers
| 1 | -$31.5M | |
| 2 | -$27.8M | |
| 3 | -$16.1M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$10.1M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$7.03M |